Literature DB >> 20596736

Novel S100A7 (psoriasin)/S100A15 (koebnerisin) subfamily: highly homologous but distinct in regulation and function.

Ronald Wolf1, Thomas Ruzicka, Stuart H Yuspa.   

Abstract

S100A7 (psoriasin) and S100A15 (koebnerisin) were first identified in inflamed psoriatic skin. They are of major interest because of their putative functional roles in innate immunity, epidermal cell maturation, and epithelial tumorigenesis. Human S100A7 and S100A15 have lately evolved by gene duplications within the epidermal differentiation complex (chromosome 1q21) during primate evolution forming a novel S100 subfamily. Therefore, S100A7 and S100A15 are almost identical in sequence (>90%) and are difficult to discriminate. Despite their high homology, S100A7 and S100A15 are distinct in tissue distribution, regulation, and function, and thus, exemplary for the diversity within the S100 family. Their different properties are compelling reasons to discriminate S100A7 (psoriasin) and S100A15 (koebnerisin) in epithelial homeostasis, inflammation, and cancer.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20596736      PMCID： PMC6410564          DOI： 10.1007/s00726-010-0666-4

Source DB:  PubMed          Journal:  Amino Acids        ISSN： 0939-4451            Impact factor:   3.520


  28 in total

1.  Spontaneous aortic rupture in a patient with neurofibromatosis type 1.

Authors:  Yang Jin Park; Keun Myoung Park; Jiyoung Oh; Hong Suk Park; Jung-Sun Kim; Young-Wook Kim
Journal:  J Korean Surg Soc       Date:  2012-03-27

2.  Solving the crystal structure of human calcium-free S100Z: the siege and conquer of one of the last S100 family strongholds.

Authors:  V Calderone; M Fragai; G Gallo; C Luchinat
Journal:  J Biol Inorg Chem       Date:  2017-01-10       Impact factor: 3.358

Review 3.  S100 proteins in cancer.

Authors:  Anne R Bresnick; David J Weber; Danna B Zimmer
Journal:  Nat Rev Cancer       Date:  2015-02       Impact factor: 60.716

4.  Differential role of psoriasin (S100A7) in estrogen receptor α positive and negative breast cancer cells occur through actin remodeling.

Authors:  Amita Sneh; Yadwinder S Deol; Akaansha Ganju; Konstantin Shilo; Thomas J Rosol; Mohd W Nasser; Ramesh K Ganju
Journal:  Breast Cancer Res Treat       Date:  2013-03-28       Impact factor: 4.872

Review 5.  Functions of S100 proteins.

Authors:  R Donato; B R Cannon; G Sorci; F Riuzzi; K Hsu; D J Weber; C L Geczy
Journal:  Curr Mol Med       Date:  2013-01       Impact factor: 2.222

6.  An integrated epigenetic and transcriptomic analysis reveals distinct tissue-specific patterns of DNA methylation associated with atopic dermatitis.

Authors:  Elke Rodríguez; Hansjörg Baurecht; Anna Franziska Wahn; Anja Kretschmer; Melanie Hotze; Sonja Zeilinger; Norman Klopp; Thomas Illig; Katharina Schramm; Holger Prokisch; Brigitte Kühnel; Christian Gieger; Jürgen Harder; Liliana Cifuentes; Natalija Novak; Stephan Weidinger
Journal:  J Invest Dermatol       Date:  2014-02-13       Impact factor: 8.551

Review 7.  Opposing functions of psoriasin (S100A7) and koebnerisin (S100A15) in epithelial carcinogenesis.

Authors:  Eva Hattinger; Stephanie Zwicker; Thomas Ruzicka; Stuart H Yuspa; Ronald Wolf
Journal:  Curr Opin Pharmacol       Date:  2013-05-09       Impact factor: 5.547

8.  Biochemical and Functional Evaluation of the Intramolecular Disulfide Bonds in the Zinc-Chelating Antimicrobial Protein Human S100A7 (Psoriasin).

Authors:  Lisa S Cunden; Megan Brunjes Brophy; Grayson E Rodriguez; Hope A Flaxman; Elizabeth M Nolan
Journal:  Biochemistry       Date:  2017-10-19       Impact factor: 3.162

Review 9.  Joining S100 proteins and migration: for better or for worse, in sickness and in health.

Authors:  Stephane R Gross; Connie Goh Then Sin; Roger Barraclough; Philip S Rudland
Journal:  Cell Mol Life Sci       Date:  2013-06-30       Impact factor: 9.261

Review 10.  Cutaneous and ocular rosacea: Common and specific physiopathogenic mechanisms and study models.

Authors:  Daniela Rodrigues-Braz; Min Zhao; Nilufer Yesilirmak; Selim Aractingi; Francine Behar-Cohen; Jean-Louis Bourges
Journal:  Mol Vis       Date:  2021-05-13       Impact factor: 2.367
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.